CN106798919A - A kind of goat immune method - Google Patents

A kind of goat immune method Download PDF

Info

Publication number
CN106798919A
CN106798919A CN201710049604.9A CN201710049604A CN106798919A CN 106798919 A CN106798919 A CN 106798919A CN 201710049604 A CN201710049604 A CN 201710049604A CN 106798919 A CN106798919 A CN 106798919A
Authority
CN
China
Prior art keywords
goat
once
vaccine
annual
september
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710049604.9A
Other languages
Chinese (zh)
Inventor
蒋纯超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lu'an Lufeng Animal Husbandry Technology Co Ltd
Original Assignee
Lu'an Lufeng Animal Husbandry Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lu'an Lufeng Animal Husbandry Technology Co Ltd filed Critical Lu'an Lufeng Animal Husbandry Technology Co Ltd
Priority to CN201710049604.9A priority Critical patent/CN106798919A/en
Publication of CN106798919A publication Critical patent/CN106798919A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a kind of goat immune method, comprise the following steps that：Heavy ewe give a birth first 20 30 days and 10 15 days, respectively to heavy ewe hypodermic injection lamb dysentery aluminium hydroxide vaccine once；At the beginning of annual 3 months, mid-September is respectively to each 1 time of lamb hypodermic injection lamb bacillus coli vaccine；Annual March to goat hypodermic injection goats contagious pleuropneumonia aluminium hydroxide vaccine once；Annual 3 April, to goat hypodermic injection sheep pox chicken embryo attenuated vaccine once；Annual March, September are each once to injecting aphtha attenuated cell freeze-dried vaccine in goat mucous membrane of mouth respectively；Annual March, September respectively it is each to goat dorsal sc injection sheep streptococcus aluminium hydroxide vaccine once；Annual March, September respectively it is each to goat intramuscular injection 5-linked seedling once；Annual mid-September to No. II anthrax vaccine of goat hypodermic injection once.The present invention is inoculated with using different vaccines according to the change of caprine growth environment to goat, reduces the goat incidence of disease, improves the economic benefit of raiser.

Description

A kind of goat immune method
Technical field
The present invention relates to a kind of goat immune method, broiler breeding technical field is applied to.
Background technology
Goat is that China's goat industry quickly grows, outstanding achievement, in China's herding earliest by one of domestic animal of mankind's domestication Area is raised extensively, and in breeding process, due to each side such as season, environment, goat is easily by extraneous infection It is sick, it is therefore desirable to which that goat is immunized, but in many small-sized plants or individual raiser, do not have systematic immune side Method, usually to certain economic loss itself is brought, certain strike is brought to the confidence of raiser.
The content of the invention
Above-mentioned to solve the problems, such as, the invention discloses a kind of goat immune method, systematicness is high, good immune effect.
The invention discloses a kind of goat immune method, comprise the following steps that：
Step one：20-30 days and 10-15 days before heavy ewe is given a birth, respectively to heavy ewe hypodermic injection lamb dysentery hydrogen Once, consumption is respectively 2ml, 3ml to aluminum oxide vaccine, and injection site is that two back legs inner side is subcutaneous；
Step 2：At the beginning of annual 3 months, mid-September respectively to each 1 time of lamb hypodermic injection lamb bacillus coli vaccine, it is only big by sheep Small, only, 3 lamb the 2ml/ more than monthly age is only for the lamb 1ml/ below 3 monthly ages；
Step 3：Annual March to goat hypodermic injection goats contagious pleuropneumonia aluminium hydroxide vaccine once, it is only big by sheep Small, only, 6 monthly age above goat 5ml/ are only for goat 3ml/ below 6 monthly ages；
Step 4：The annual 3-4 months, consumption is 0.5ml/ to goat hypodermic injection sheep pox chicken embryo attenuated vaccine once；
Step 5：Annual March, September are each once to injecting aphtha attenuated cell freeze-dried vaccine in goat mucous membrane of mouth respectively, prevent mountain Sore mouth virus, consumption is 0.2ml/；
Step 6：Annual March, September respectively it is each to goat dorsal sc injection sheep streptococcus aluminium hydroxide vaccine once, by sheep only Size, 6 monthly ages following inoculum concentration is 3ml/, and 6 monthly age above inoculum concentrations are 5ml/；
Step 7：Annual March, September respectively it is each to goat intramuscular injection 5-linked seedling once, inoculum concentration be 5ml/ only；
Step 8：Annual mid-September, to No. II anthrax vaccine of goat hypodermic injection once inoculum concentration was 1ml/.
Using the technical program, the beneficial effects of the invention are as follows：According to the conversion of goat living environment, different epidemic diseases is used Seedling is immunized to goat, reduces the possibility of goat morbidity, improves goat survival rate, it is ensured that the economic effect of raiser Benefit.
Specific embodiment
The invention discloses a kind of goat immune method, comprise the following steps that：
Step one：20-30 days and 10-15 days before heavy ewe is given a birth, respectively to heavy ewe hypodermic injection lamb dysentery hydrogen Once, consumption is respectively 2ml, 3ml to aluminum oxide vaccine, and injection site is that two back legs inner side is subcutaneous；
Step 2：At the beginning of annual 3 months, mid-September respectively to each 1 time of lamb hypodermic injection lamb bacillus coli vaccine, it is only big by sheep Small, only, 3 lamb the 2ml/ more than monthly age is only for the lamb 1ml/ below 3 monthly ages；
Step 3：Annual March to goat hypodermic injection goats contagious pleuropneumonia aluminium hydroxide vaccine once, it is only big by sheep Small, only, 6 monthly age above goat 5ml/ are only for goat 3ml/ below 6 monthly ages；
Step 4：The annual 3-4 months, consumption is 0.5ml/ to goat hypodermic injection sheep pox chicken embryo attenuated vaccine once；
Step 5：Annual March, September are each once to injecting aphtha attenuated cell freeze-dried vaccine in goat mucous membrane of mouth respectively, prevent mountain Sore mouth virus, consumption is 0.2ml/；
Step 6：Annual March, September respectively it is each to goat dorsal sc injection sheep streptococcus aluminium hydroxide vaccine once, by sheep only Size, 6 monthly ages following inoculum concentration is 3ml/, and 6 monthly age above inoculum concentrations are 5ml/；
Step 7：Annual March, September respectively it is each to goat intramuscular injection 5-linked seedling once, inoculum concentration be 5ml/ only；
Step 8：Annual mid-September, to No. II anthrax vaccine of goat hypodermic injection once inoculum concentration was 1ml/.
Finally it should be noted that：Above example is only used to illustrate the present invention and not limit technology described in the invention Scheme；Therefore, although this specification with reference to each above-mentioned embodiment to present invention has been detailed description, this Field it is to be appreciated by one skilled in the art that still can be modified to the present invention or equivalent；And all do not depart from this The technical scheme of the spirit and scope of invention and its improvement, it all should cover in scope of the presently claimed invention.

Claims (1)

1. a kind of goat immune method, it is characterised in that comprise the following steps that：
Step one：20-30 days and 10-15 days before heavy ewe is given a birth, respectively to heavy ewe hypodermic injection lamb dysentery hydrogen Once, consumption is respectively 2ml, 3ml to aluminum oxide vaccine, and injection site is that two back legs inner side is subcutaneous；
Step 2：At the beginning of annual 3 months, mid-September respectively to each 1 time of lamb hypodermic injection lamb bacillus coli vaccine, it is only big by sheep Small, only, 3 lamb the 2ml/ more than monthly age is only for the lamb 1ml/ below 3 monthly ages；
Step 3：Annual March to goat hypodermic injection goats contagious pleuropneumonia aluminium hydroxide vaccine once, it is only big by sheep Small, only, 6 monthly age above goat 5ml/ are only for goat 3ml/ below 6 monthly ages；
Step 4：The annual 3-4 months, consumption is 0.5ml/ to goat hypodermic injection sheep pox chicken embryo attenuated vaccine once；
Step 5：Annual March, September are each once to injecting aphtha attenuated cell freeze-dried vaccine in goat mucous membrane of mouth respectively, prevent mountain Sore mouth virus, consumption is 0.2ml/；
Step 6：Annual March, September respectively it is each to goat dorsal sc injection sheep streptococcus aluminium hydroxide vaccine once, by sheep only Size, 6 monthly ages following inoculum concentration is 3ml/, and 6 monthly age above inoculum concentrations are 5ml/；
Step 7：Annual March, September respectively it is each to goat intramuscular injection 5-linked seedling once, inoculum concentration be 5ml/ only；
Step 8：Annual mid-September, to No. II anthrax vaccine of goat hypodermic injection once inoculum concentration was 1ml/.
CN201710049604.9A 2017-01-23 2017-01-23 A kind of goat immune method Withdrawn CN106798919A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710049604.9A CN106798919A (en) 2017-01-23 2017-01-23 A kind of goat immune method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710049604.9A CN106798919A (en) 2017-01-23 2017-01-23 A kind of goat immune method

Publications (1)

Publication Number Publication Date
CN106798919A true CN106798919A (en) 2017-06-06

Family

ID=58987245

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710049604.9A Withdrawn CN106798919A (en) 2017-01-23 2017-01-23 A kind of goat immune method

Country Status (1)

Country Link
CN (1) CN106798919A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109453371A (en) * 2018-11-23 2019-03-12 中国兽医药品监察所 A kind of sheep pox, goats contagious pleuropneumonia bivalent inactivated vaccine and its production method
CN110819684A (en) * 2019-09-04 2020-02-21 中国农业科学院兰州兽医研究所 Method for comparing virulence of mycoplasma capricolum goat pneumonia subspecies strain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104958760A (en) * 2015-03-27 2015-10-07 中牧实业股份有限公司 Goat inactivated vaccine and preparation method thereof
CN105343875A (en) * 2015-10-21 2016-02-24 颍上县嘉鸣蛋鸡养殖有限公司 Growing chicken immunization method
CN106075429A (en) * 2016-08-16 2016-11-09 中国农业科学院兰州兽医研究所 A kind of goatpox, sheep pox, sore mouth virus three cell weak-toxic vaccine and its production and use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104958760A (en) * 2015-03-27 2015-10-07 中牧实业股份有限公司 Goat inactivated vaccine and preparation method thereof
CN105343875A (en) * 2015-10-21 2016-02-24 颍上县嘉鸣蛋鸡养殖有限公司 Growing chicken immunization method
CN106075429A (en) * 2016-08-16 2016-11-09 中国农业科学院兰州兽医研究所 A kind of goatpox, sheep pox, sore mouth virus three cell weak-toxic vaccine and its production and use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ZHANGYUN95555: "山羊免疫程序表", 《道客巴巴》 *
刘华等: "山羊的免疫程序", 《河南畜牧兽医》 *
杲罡: "肉用山羊的免疫", 《农村养殖技术》 *
王惠生: "羊场免疫程序", 《科学种养》 *
田正康等: "肉用山羊常见传染病的免疫", 《畜牧与饲料科学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109453371A (en) * 2018-11-23 2019-03-12 中国兽医药品监察所 A kind of sheep pox, goats contagious pleuropneumonia bivalent inactivated vaccine and its production method
CN110819684A (en) * 2019-09-04 2020-02-21 中国农业科学院兰州兽医研究所 Method for comparing virulence of mycoplasma capricolum goat pneumonia subspecies strain
CN110819684B (en) * 2019-09-04 2022-09-13 中国农业科学院兰州兽医研究所 Method for comparing virulence of mycoplasma capricolum goat pneumonia subspecies strain

Similar Documents

Publication Publication Date Title
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
AP2002002568A0 (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals.
JP2021506782A (en) Vaccine to protect against streptococcal infection
CN112870341B (en) Goat infectious pleuropneumonia subunit vaccine and preparation method and application thereof
CN106798919A (en) A kind of goat immune method
Lee et al. Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin
AU2013370982C1 (en) Immunogenic composition comprising mycoplasma antigens
CN109055255B (en) Mycoplasma hyopneumoniae culture medium, preparation method and application thereof in vaccines
CN103495167B (en) A kind of preparation method of chicken infection bursal disease composite live vaccine
NO20090290L (en) Polyvalent vaccine against salmonid alphavirus infections
CN110694058B (en) Rabbit coccidiosis live vaccine and preparation method and application thereof
KR101245029B1 (en) Vaccine composition for Korean Porcine reproductive and respiratory syndrome virus
WO2016119078A1 (en) Combined use of haemophilus parasuis lc strain and lz-20100109 strain
US10124057B2 (en) Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck
CN109385385B (en) Preparation method and application of mycoplasma avium culture medium and mycoplasma avium bacterial liquid
CN104288760A (en) Vaccine composition, and preparation method and application thereof
CN107875377B (en) Preparation method of clostridium perfringens type E toxoid vaccine
JPS6327437A (en) Live vaccine for infectious disease of chicken
RU2329828C1 (en) Method of production of vaccine for animal necrobacteriosis prevention and treatment, vaccine for animal necrobacteriosis prevention and treatment and method of animal necrobacteriosis prevention and treatment
KR102077701B1 (en) Vaccin composition containing novel inactivated Salmonella Gallinarum whole cells for preventing or treating Fowl Typhoid
MX2021015155A (en) Rhamnose-polysaccharides.
FI3334454T3 (en) Mycoplasma bovis compositions
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella
CN110974952A (en) Novel adjuvant CpG-ODN streptococcus suis 2+9 type bivalent inactivated vaccine and preparation method thereof
CN106492214A (en) A kind of Immune Profile In Chicks method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20170606

WW01 Invention patent application withdrawn after publication